QHP Capital-backed Azurity Pharmaceuticals completed the acquisition of Covis Pharma.

QHP Capital-backed Azurity Pharmaceuticals, a specialty pharmaceutical company, completed the acquisition of Covis Pharma, a specialty pharmaceutical company. Financial terms were not disclosed. "We are excited to welcome Covis Pharma to Azurity. The efforts of colleagues at both companies, their devotion to overlooked patients, and our culture of execution have brought us together to build this unique, highly differentiated pharmaceutical company. I look forward to all that we will accomplish as we grow globally and embrace new opportunities, driven by our purpose," Ronald Scarboro, Azurity CEO.